Sir Andrew Pollard: The war on Covid-19

“The change that we're going to see happen with AI does mean that there's going to be some really difficult challenges and times ahead. But the question is, how do we get to both navigating those challenges as humanly and as gracefully as possible, and how do we get to the same k ...  Show more

“Historically, as a region, we’ve been extracted at two levels. If you look at the AI value chain, a lot of our youth, some who have studied computer science, are left at data labelling roles at the bottom of the value chain, where the least value is created. In a different way, ...  Show more

The lofty ambition of the global community was that across the globe, those with the highest risk of losing their lives to this virus should be vaccinated first. With 99% of deaths coming in the over fifties, the plan was that everybody in this age group should be inoculated.But ...  Show more

This past year, scientists racing to stop the novel coronavirus delivered vaccines at a pace and scale the world has never seen before. Adrian Hill, director of Oxford University's vaccine research institute, recounts how he and his team developed the AstraZeneca vaccine. He expl ...  Show more

The new Omicron variant poses a potential risk of spiralling coronavirus infections globally and governments around the world are putting plans in place to tackle it. One solutions is to make Covid vaccines compulsory. This week, Ros Atkins, looks at the debate around Covid vacci ...  Show more

A great day for science, a bad day for Covid-19. As the first Pfizer vaccines are given to patients in the UK, the Oxford-AstraZeneca vaccine publishes its data. Adam and Fergus chat to virologist Dr Elisabetta Groppelli about how the rollout might go - and learn some Italian whi ...  Show more